OR WAIT null SECS
June 02, 2020
The global COVID-19 pandemic has highlighted the need for the pharmaceutical industry to strengthen its supply chain.
May 27, 2020
A network-based supply chain approach has the potential to improve resilience and performance.
May 20, 2020
US manufacturers focus on preparing capacity while vaccines and treatments for COVID-19 are being developed and tested.
May 19, 2020
Evonik opened a new facility for GMP manufacturing of bioresorbable polymers and excipients for pharmaceutical and medical applications in Birmingham, AL.
May 06, 2020
Quartic.ai and Bright Path Laboratories have agreed to develop an artificial intelligence (AI)-powered continuous manufacturing platform for APIs and other small-molecule drugs using Bright Path Labs’ continuous bioreactor and the Quartic.ai smart manufacturing technology.
CMO Evonik begins capacity expansion of APIs and intermediates at its sites in Dossenheim and Hanau Germany to increase EU supply security for drug products.
April 23, 2020
Wavelength Pharmaceuticals expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients in the COVID-19 pandemic.
April 15, 2020
Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs.
April 08, 2020
The agency has been tasked with coordinating efforts to mitigate shortages of medicines within Europe during the COVID-19 pandemic.
April 02, 2020
More sustainable and functional packaging protects temperature-sensitive drugs.